Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Eltrombopag; Drug: Eltrombopag
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Condition: Coronary Artery Disease
Intervention: Drug: Omacor, omega-3 fatty acids in CAD patients
Sponsors: HeartDrug Research LLC; University of Oslo
Not yet recruiting - verified March 2010
Condition: Severe Hemophilia A
Interventions: Drug: FVIII Concentrates; Drug: FVIII/VWF concentrates
Sponsors: City of Hope Medical Center; Grifols Biologicals Inc.; CSL Behring; Talecris Biotherapeutics; Biotest Pharmaceuticals Corporation
Recruiting - verified March 2010
Condition: Osteoarthritis
Intervention: Procedure: Total knee arthroplasty
Sponsor: Exactech
Recruiting - verified March 2010
Condition: Chronic Myeloid Leukemia
Intervention: Other: Discontinuation of therapy
Sponsor: University of Michigan Cancer Center
Recruiting - verified February 2010
Condition: Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Intervention: Biological: Romiplostim
Sponsor: Amgen
Recruiting - verified March 2010
Condition: Coronary Artery Disease
Interventions: Drug: prasugrel; Drug: clopidogrel
Sponsor: Daiichi Sankyo Inc.
Recruiting - verified February 2010
Condition: Immune Thrombocytopenic Purpura
Interventions: Drug: Dexamethasone USP Micronized; Drug: Prednisone
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2010
Conditions: Hepatitis C; Thrombocytopaenia
Intervention: Drug: Eltrombopag
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Primary Myelofibrosis; Post-Polycythemia Vera; Post-Essential Thrombocytopenia
Interventions: Drug: Panobinostat; Drug: Panobinostat
Sponsor: Novartis
Recruiting - verified March 2010
Condition: Immune Thrombocytopenic Purpura
Interventions: Drug: eltrombopag; Drug: Placebo
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Thrombocytopenia; Idiopathic Thrombocytopenic Purpura
Intervention: Biological: romiplostim
Sponsor: Amgen
Recruiting - verified March 2010
Conditions: Advanced Myelodysplastic Syndrome; Myelodysplastic Syndrome; Secondary Acute Myeloid Leukemia After MDS; Thrombocytopenia
Interventions: Drug: eltrombopag olamine; Other: Placebo
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Ovarian Neoplasms
Interventions: Biological: IMC-3G3; Drug: liposomal doxorubicin
Sponsor: ImClone LLC
Recruiting - verified February 2010
Conditions: Wiskott-Aldrich Syndrome (WAS); X-linked Thrombocytopenia
Intervention: Drug: Interleukin-2
Sponsors: Children's Hospital of Philadelphia; Novartis
Recruiting - verified March 2010
Condition: Thrombocytopenia
Intervention:
Sponsors: Christiana Care Health Services; Alfred I. duPont Hospital for Children; Thomas Jefferson University; Abington Memorial Hospital
Recruiting - verified March 2010
Conditions: Myelofibrosis; Myeloproliferative Disorders; Polycythemia Vera; Essential Thrombocythemia
Intervention: Drug: SB1518
Sponsor: S*BIO
Recruiting - verified March 2010
Conditions: Myelofibrosis; Essential Thrombocythemia; Polycythemia Vera
Intervention: Drug: CEP-701 (Lestaurtinib)
Sponsor: Myeloproliferative Disorders-Research Consortium
Recruiting - verified February 2010
Conditions: Myelofibrosis; Idiopathic Myelofibrosis; Essential Thrombocythemia; Polycythemia Vera
Intervention:
Sponsor: Myeloproliferative Disorders-Research Consortium
Recruiting - verified February 2010
Conditions: Polycythemia Vera; Essential Thrombocythemia; Idiopathic Myelofibrosis
Intervention:
Sponsor: Myeloproliferative Disorders-Research Consortium
Recruiting - verified February 2010
Conditions: Myeloproliferative Disease; Myelofibrosis; Idiopathic Myelofibrosis; Essential Thrombocythemia; Polycythemia Vera
Intervention:
Sponsor: Myeloproliferative Disorders-Research Consortium
Recruiting - verified February 2010
Conditions: MDS; Myelodysplastic Syndromes; Thrombocytopenia
Interventions: Drug: Placebo; Biological: Romiplostim
Sponsor: Amgen
Recruiting - verified March 2010
Condition: Von Willebrand Disease
Intervention: Biological: Alphanate SD/HT
Sponsor: Grifols Biologicals Inc.
Recruiting - verified March 2010
Condition: Chronic Idiopathic Thrombocytopenic Purpura
Interventions: Biological: Gammaplex, intravenous immunoglobulin; Biological: Gammaplex; Biological: Gammaplex
Sponsor: Bio Products Laboratory
Recruiting - verified March 2010
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: eltrombopag olamine (SB-497115-GR)
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Brain and Central Nervous System Tumors; Drug/Agent Toxicity by Tissue/Organ; Lymphoma; Thrombocytopenia
Interventions: Biological: filgrastim; Biological: pegfilgrastim; Biological: rituximab; Drug: blood-brain barrier disruption chemotherapy; Drug: carboplatin; Drug: cyclophosphamide; Drug: cytarabine; Drug: etoposide; Drug: etoposide phosphate; Drug: sodium thiosulfate
Sponsors: OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified June 2009
All Categories ... Medical Conditions » ... Blood Disorders » ... Platelet Disorders 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
